相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity
Mehdi Mollapour et al.
Oncotarget (2015)
Chaperones and the maturation of steroid hormone receptor complexes
Yizhi Jane Tao et al.
Oncotarget (2015)
Survivin Signaling in Clinical Oncology: A Multifaceted Dragon
Jagat R. Kanwar et al.
MEDICINAL RESEARCH REVIEWS (2013)
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Len Neckers et al.
CLINICAL CANCER RESEARCH (2012)
WEE1 Inhibition Sensitizes Basal Breast Cancer Cells to TRAIL-Induced Apoptosis
Sireesha V. Garimella et al.
MOLECULAR CANCER RESEARCH (2012)
MK1775, a Selective Wee1 Inhibitor, Shows Single-Agent Antitumor Activity against Sarcoma Cells
Jenny M. Kreahling et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Survivin Is a Therapeutic Target in Merkel Cell Carcinoma
Reety Arora et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Survivin in Solid Tumors: Rationale for Development of Inhibitors
David N. Church et al.
CURRENT ONCOLOGY REPORTS (2012)
Endogenous Angiogenesis Inhibitor Blocks Tumor Growth via Direct and Indirect Effects on Tumor Microenvironment
Dimitra Bourboulia et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Foundation review: Antiangiogenic therapy using nanotechnological-based delivery system
Jagat R. Kanwar et al.
DRUG DISCOVERY TODAY (2011)
Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib
Nickolay Neznanov et al.
ONCOTARGET (2011)
Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome
Lyndsay M. Murrow et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
MK-1775, a small molecule Wee1 inhibitor, enhances antitumor efficacy of various DNA-damaging agents, including 5-fluorouracil
Hiroshi Hirai et al.
CANCER BIOLOGY & THERAPY (2010)
Hsp90 phosphorylation, Wee1, and the cell cycle
Mehdi Mollapour et al.
CELL CYCLE (2010)
Swe1Wee1-Dependent Tyrosine Phosphorylation of Hsp90 Regulates Distinct Facets of Chaperone Function
Mehdi Mollapour et al.
MOLECULAR CELL (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
Survivin as a global target of intrinsic tumor suppression networks
Minakshi Guha et al.
CELL CYCLE (2009)
Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy
Giuseppe Giaccone et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2008)
Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone
Akihiro Yano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1.: Structure-activity relationships for chromophore modification and phenyl ring substitution
Brian D. Palmer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
Mechanisms of cytochrome c release from mitochondria
C. Garrido et al.
CELL DEATH AND DIFFERENTIATION (2006)
Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models
U Banerji et al.
CLINICAL CANCER RESEARCH (2005)
Hsp90 chaperone complexes are required for the activity and stability of yeast protein kinases Mik1, Wee1 and Swe1
FS Goes et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
分享论文
